Mostrar el registro sencillo del ítem
| dc.contributor.author | Tangri, Navdeep | |
| dc.contributor.author | Álvarez, Christian-S | |
| dc.contributor.author | Arnold, Matthew | |
| dc.contributor.author | Barone, Salvatore | |
| dc.contributor.author | Cebrián, Ana | |
| dc.contributor.author | Chen, Hungta | |
| dc.contributor.author | de-Nicola, Luca | |
| dc.contributor.author | Jarbrink, Krister | |
| dc.contributor.author | Kanumilli, Naresh | |
| dc.contributor.author | Lim, Kean-Seng | |
| dc.contributor.author | Moriyama, Toshiki | |
| dc.contributor.author | Pecoits-Filho, Roberto | |
| dc.contributor.author | Ribeiro-de-Castro, María-Cristina | |
| dc.contributor.author | Santamaria, Rafael | |
| dc.contributor.author | Schneider, Markus-P | |
| dc.contributor.author | Virgitti, Jean-Blaise | |
| dc.contributor.author | Kushner, Pamela | |
| dc.date.accessioned | 2025-11-20T07:25:36Z | |
| dc.date.available | 2025-11-20T07:25:36Z | |
| dc.date.issued | 2024-11 | |
| dc.identifier.citation | Tangri N, Alvarez CS, Arnold M, Barone S, Cebrián A, Chen H, et al. Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: Insights from REVEAL - CKD. Eur J Clin Investigation. noviembre de 2024;54(11):e14282. | |
| dc.identifier.issn | 0014-2972 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/21594 | |
| dc.description.abstract | BACKGROUND: Clinical practice guidelines for patients with chronic kidney disease (CKD) recommend regular monitoring and management of kidney function and CKD risk factors. However, the majority of patients with stage 3 CKD lack a diagnosis code, and data on the implementation of these recommendations in the real world are limited. AIM: To assess the implementation of guideline-directed monitoring and management practices in the real world in patients with stage 3 CKD without a recorded diagnosis code. METHODS: REVEAL-CKD (NCT04847531) is a multinational, observational study of patients with stage 3 CKD. Eligible patients had ?2 consecutive estimated glomerular filtration rate (eGFR) measurements indicative of stage 3 CKD recorded >90 and ?730 days apart, lacked an International Classification of Diseases 9/10 diagnosis code corresponding to CKD any time before and up to 6 months after the second eGFR measurement. Testing of key measures of care quality were assessed. RESULTS: The study included 435,971 patients from 9 countries. In all countries, the prevalence of urinary albumin-creatinine ratio and albuminuria testing was low. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker and statin prescriptions were highly variable, and sodium-glucose cotransporter-2 inhibitor prescriptions remained below 21%. Blood pressure measurements were recorded in 20.2%-89.9% of patients. CONCLUSIONS: Overall, a large proportion of patients with evidence of stage 3 CKD did not receive recommended, guideline-directed monitoring and management. The variability in standard of care among countries demonstrates a clear opportunity to improve monitoring and management of these patients, most likely improving long-term outcomes. | |
| dc.language.iso | eng | |
| dc.publisher | WILEY | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | |
| dc.rights.uri | Atribución-NoComercial-SinDerivadas 3.0 España | * |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Glomerular Filtration Rate | |
| dc.subject.mesh | Renal Insufficiency, Chronic/physiopathology | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | |
| dc.subject.mesh | Angiotensin Receptor Antagonists/therapeutic use | |
| dc.subject.mesh | Albuminuria | |
| dc.subject.mesh | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | |
| dc.subject.mesh | Guideline Adherence | |
| dc.subject.mesh | Sodium-Glucose Transporter 2 Inhibitors/therapeutic use | |
| dc.subject.mesh | Creatinine | |
| dc.subject.mesh | Blood Pressure/physiology | |
| dc.subject.mesh | Practice Guidelines as Topic | |
| dc.title | Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: Insights from REVEAL-CKD | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 39023418 | |
| dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/10.1111/eci.14282 | |
| dc.identifier.doi | 10.1111/eci.14282 | |
| dc.journal.title | European Journal of Clinical Investigation | |
| dc.identifier.essn | 1365-2362 |